ScoreWhy is Anthem Biosciences Ltd ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 19.93%
- Healthy long term growth as Operating profit has grown by an annual rate 44.32%
- The company is Net-Debt Free
- PBT LESS OI(Q) At Rs 119.69 cr has Fallen at -30.9% (vs previous 4Q average)
- PAT(Q) At Rs 119.94 cr has Fallen at -21.2% (vs previous 4Q average)
- NET SALES(Q) Lowest at Rs 418.22 cr
2
With ROE of 20, it has a Very Expensive valuation with a 15.6 Price to Book Value
- Over the past year, while the stock has generated a return of 12.04%, its profits have risen by 36%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -3.26% over the previous quarter and currently hold 71.42% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Anthem Bioscienc should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Anthem Bioscienc for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Anthem Bioscienc
12.04%
0.39
30.50%
Sensex
-2.63%
-0.19
13.57%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.80%
EBIT Growth (5y)
44.32%
EBIT to Interest (avg)
92.24
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.63
Tax Ratio
26.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.05%
ROCE (avg)
32.62%
ROE (avg)
19.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
80
Industry P/E
37
Price to Book Value
15.55
EV to EBIT
70.85
EV to EBITDA
58.55
EV to Capital Employed
21.54
EV to Sales
23.19
PEG Ratio
NA
Dividend Yield
0.24%
ROCE (Latest)
32.47%
ROE (Latest)
20.02%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PAT(Latest six months)
At Rs 309.03 cr has Grown at 41.49%
-14What is not working for the Company
PBT LESS OI(Q)
At Rs 119.69 cr has Fallen at -30.9% (vs previous 4Q average
PAT(Q)
At Rs 119.94 cr has Fallen at -21.2% (vs previous 4Q average
NET SALES(Q)
Lowest at Rs 418.22 cr
PBDIT(Q)
Lowest at Rs 150.57 cr.
Loading Valuation Snapshot...
Here's what is not working for Anthem Bioscienc
Net Sales - Quarterly
At Rs 418.22 cr has Fallen at -21.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 531.08 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 119.69 cr has Fallen at -30.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 173.21 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 119.94 cr has Fallen at -21.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 152.29 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 418.22 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 150.57 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 119.69 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
